SN003 is a reversible antagonist of corticotropin-releasing factor receptor 1 (CRFR1) with an IC50 of 241 nM, exhibiting over 1000-fold selectivity over CRFR2; it inhibits CRF-induced adrenocorticotropic hormone (ACTH) release in vitro and alleviates depression-like behaviors in rats.